These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30924493)

  • 1. The colon as an energy salvage organ for children with short bowel syndrome.
    Norsa L; Lambe C; Abi Abboud S; Barbot-Trystram L; Ferrari A; Talbotec C; Kapel N; Pigneur B; Goulet O
    Am J Clin Nutr; 2019 Apr; 109(4):1112-1118. PubMed ID: 30924493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation of plasma citrulline as a predictive factor for weaning off long-term parenteral nutrition in children with neonatal short bowel syndrome.
    Proli F; Faragalli A; Talbotec C; Bucci A; Zemrani B; Chardot C; Abi Nader E; Goulet O; Lambe C
    Clin Nutr; 2021 Aug; 40(8):4941-4947. PubMed ID: 34358840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum citrulline: a potential marker for intestinal epithelial mass and absorption capacity in short bowel syndrome patients].
    Gong JF; Zhu WM; Li N; Liu FN; Tan L; Luo N; Li JS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):333-7. PubMed ID: 17659456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma citrulline concentration as a biomarker of intestinal function in short bowel syndrome and in intestinal transplant].
    Vecino López R; Andrés Moreno AM; Ramos Boluda E; Martinez-Ojinaga Nodal E; Hernanz Macías A; Prieto Bozano G; Lopez Santamaria M; Tovar Larrucea JA
    An Pediatr (Barc); 2013 Oct; 79(4):218-23. PubMed ID: 23528708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.
    Lambe C; Talbotec C; Kapel N; Barbot-Trystram L; Brabant S; Nader EA; Pigneur B; Payen E; Goulet O
    Am J Clin Nutr; 2023 Jun; 117(6):1152-1163. PubMed ID: 37270289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma citrulline as marker of bowel adaptation in children with short bowel syndrome.
    Diamanti A; Panetta F; Gandullia P; Morini F; Noto C; Torre G; Lezo A; Goffredo B; Daniele A; Gambarara M
    Langenbecks Arch Surg; 2011 Oct; 396(7):1041-6. PubMed ID: 21630079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma citrulline concentration as a biomarker for bowel loss and adaptation in hospitalized pediatric patients requiring parenteral nutrition.
    Stultz JS; Tillman EM; Helms RA
    Nutr Clin Pract; 2011 Dec; 26(6):681-7. PubMed ID: 22205556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.
    Messing B; Crenn P; Beau P; Boutron-Ruault MC; Rambaud JC; Matuchansky C
    Gastroenterology; 1999 Nov; 117(5):1043-50. PubMed ID: 10535866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum citrulline levels and progression to parenteral nutrition independence in children with short bowel syndrome.
    Fitzgibbons S; Ching YA; Valim C; Zhou J; Iglesias J; Duggan C; Jaksic T
    J Pediatr Surg; 2009 May; 44(5):928-32. PubMed ID: 19433172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome.
    Rhoads JM; Plunkett E; Galanko J; Lichtman S; Taylor L; Maynor A; Weiner T; Freeman K; Guarisco JL; Wu GY
    J Pediatr; 2005 Apr; 146(4):542-7. PubMed ID: 15812462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome?
    Luo M; Fernández-Estívariz C; Manatunga AK; Bazargan N; Gu LH; Jones DP; Klapproth JM; Sitaraman SV; Leader LM; Galloway JR; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2007; 31(1):1-7. PubMed ID: 17202433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human growth hormone on intestinal absorption and body composition in children with short bowel syndrome.
    Goulet O; Dabbas-Tyan M; Talbotec C; Kapel N; Rosilio M; Souberbielle JC; Corriol O; Ricour C; Colomb V
    JPEN J Parenter Enteral Nutr; 2010; 34(5):513-20. PubMed ID: 20852179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome.
    Amiot A; Messing B; Corcos O; Panis Y; Joly F
    Clin Nutr; 2013 Jun; 32(3):368-74. PubMed ID: 22992308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased intestinal permeability in patients with short bowel syndrome is not affected by parenteral nutrition.
    Cinkajzlová A; Lacinová Z; Kloučková J; Kaválková P; Kratochvílová H; Křížová J; Trachta P; Mráz M; Haluzík M
    Physiol Res; 2019 Oct; 68(5):817-825. PubMed ID: 31424246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma citrulline is not a biomarker for intestinal adaptation in short bowel syndrome, studied in piglets: a model for human neonates.
    Lansing M; Turner JM; Wizzard P; Lavallee CM; Lim DW; Muto M; Nation PN; Pencharz PB; Ball RO; Wales PW
    Pediatr Surg Int; 2019 Jun; 35(6):657-663. PubMed ID: 30937511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of various pediatric short bowel syndrome in China.
    Zhang T; Feng H; Cao Y; Tao Y; Lu L; Yan W; Li F; Wang Y; Cai W
    Pediatr Surg Int; 2021 Apr; 37(4):495-502. PubMed ID: 33394086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity.
    Peters JH; Wierdsma NJ; Teerlink T; van Leeuwen PA; Mulder CJ; van Bodegraven AA
    Am J Gastroenterol; 2007 Dec; 102(12):2814-9. PubMed ID: 17764491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome.
    Bailly-Botuha C; Colomb V; Thioulouse E; Berthe MC; Garcette K; Dubern B; Goulet O; Couderc R; Girardet JP
    Pediatr Res; 2009 May; 65(5):559-63. PubMed ID: 19127207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome.
    Santarpia L; Catanzano F; Ruoppolo M; Alfonsi L; Vitale DF; Pecce R; Pasanisi F; Contaldo F; Salvatore F
    Ann Nutr Metab; 2008; 53(2):137-42. PubMed ID: 18997462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.